Document is current
Any future updates will be listed below
-
Authors
des Déserts, Marc Danguy https://orcid.org/0000-0002-0185-9955
de Moreuil, Claire https://orcid.org/0000-0003-1142-0978
Elhasnaoui, Jamal https://orcid.org/0000-0001-9311-0417
Gourhant, Lenaïck https://orcid.org/0000-0002-5761-8480
Gourdou-Latyszenok, Virginie https://orcid.org/0000-0002-1595-2528
Espinasse, Benjamin https://orcid.org/0000-0003-2523-9491
Menguy, Juliette
Tromeur, Cécile https://orcid.org/0000-0001-9161-7521
Corre, Rozenn Le https://orcid.org/0000-0002-5621-074X
Mao, Raphael Le https://orcid.org/0000-0003-4489-5697
Kraemmer, Daniel https://orcid.org/0000-0002-8845-081X
Sanchez, Olivier https://orcid.org/0000-0003-1633-8391
Couturaud, Francis https://orcid.org/0000-0002-1855-8032
Lemarié, Catherine A. https://orcid.org/0000-0002-3897-4287
,
-
Funding
Funding for this research was provided by:
Ministère des Affaires Sociales et de la Santé (Ministère des Affaires Sociales et de la Santé)
- License Information
-
More Information
Article History
Accepted: 8 May 2025
First Online: 22 June 2025
Declarations
:
: Dr. Couturaud reports having received research grant support from Bristol-Myers Squibb/Pfizer and Bayer and fees for board memberships or symposia from Bayer, Bristol-Myers Squibb/Pfizer, Merck Sharp and Dohme, Sanofi, Leo Pharma, Janssen and Astra Zeneca and having received travel support from Bayer, Bristol-Myers Squibb/Pfizer, Leo Pharma, Pfizer.
